Stock 4506 SUMITOMO PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 07:00:00 26/04/2024 BST 		5-day change 1st Jan Change
410 JPY +2.50% Intraday chart for Sumitomo Pharma Co., Ltd. +5.40% -12.02%
04-22 Lull in Geopolitical Tensions Lifts Asian Stock Markets MT
04-17 Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold MT

Business Summary

Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;

- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.

Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).

Number of employees: 6,250

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
91.9 %
520,177 92.9 % 510,722 91.9 % -1.82%
Other
8.1 %
39,858 7.1 % 44,822 8.1 % +12.45%

Sales per region

JPY in Million2022Weight2023Weight Delta
North America
59.1 %
319,790 57.1 % 328,467 59.1 % +2.71%
Japan
22.7 %
149,915 26.8 % 126,106 22.7 % -15.88%
Global
8.1 %
39,858 7.1 % 44,822 8.1 % +12.45%
China
7.1 %
38,296 6.8 % 39,397 7.1 % +2.87%
Other Overseas
3.0 %
12,176 2.2 % 16,752 3.0 % +37.58%

Managers

Managers TitleAgeSince
Hiroshi Nomura CEO
 Chief Executive Officer 66 30/09/05
Masayo Tada CHM
 Chairman 79 30/09/05
Yoshiharu Ikeda CTO
 Chief Tech/Sci/R&D Officer - -
Kenji Ueno CTO
 Chief Tech/Sci/R&D Officer - -
Isao Shimizu CTO
 Chief Tech/Sci/R&D Officer - -
Yutaka Atomi BRD
 Director/Board Member 79 31/05/13
Nobuhiko Tamura BRD
 Director/Board Member 68 31/10/09
Toru Kimura BRD
 Director/Board Member 63 31/05/09
Hitoshi Odagiri BRD
 Director/Board Member 67 31/03/12
Atsuko Higuchi IRO
 Public Communications Contact - -

Members of the board

Members of the board TitleAgeSince
Saeko Arai BRD
 Director/Board Member 60 31/05/18
Nobuhiro Endo BRD
 Director/Board Member 70 31/05/19
Masayo Tada CHM
 Chairman 79 30/09/05
Minoru Usui BRD
 Director/Board Member 69 -
Nobuhiko Tamura BRD
 Director/Board Member 68 31/10/09
Yoshiharu Ikeda CTO
 Chief Tech/Sci/R&D Officer - -
Hiroshi Nomura CEO
 Chief Executive Officer 66 30/09/05
Hitoshi Odagiri BRD
 Director/Board Member 67 31/03/12
Toru Kimura BRD
 Director/Board Member 63 31/05/09
Yutaka Atomi BRD
 Director/Board Member 79 31/05/13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 397,900,154 168,148,626 ( 42.26 %) 609,052 ( 0.1531 %) 42.26 %

Shareholders

NameEquities%Valuation
SUMITOMO CHEMICAL CO., LTD.
51.68 %
205,634,000 51.68 % 541 M ¥
INABATA & CO.,LTD.
2.207 %
8,782,000 2.207 % 23 M ¥
Nippon Life Insurance Co.
1.905 %
7,581,000 1.905 % 20 M ¥
Sumitomo Mitsui Banking Pension Fund
1.759 %
7,000,000 1.759 % 18 M ¥
Sumitomo Life Insurance Co.
1.452 %
5,776,000 1.452 % 15 M ¥
Sumitomo Pharma Employee Stock Ownership Plan
0.8273 %
3,292,000 0.8273 % 9 M ¥
MS&AD INSURANCE GROUP HOLDINGS, INC.
0.6688 %
2,661,000 0.6688 % 7 M ¥
ONO PHARMACEUTICAL CO., LTD.
0.5396 %
2,147,102 0.5396 % 6 M ¥
MEDIPAL HOLDINGS CORPORATION
0.2317 %
921,788 0.2317 % 2 M ¥
MOCHIDA PHARMACEUTICAL CO., LTD.
0.2295 %
913,000 0.2295 % 2 M ¥

Holdings

NameEquities%Valuation
MEDIPAL HOLDINGS CORPORATION
1.47%
 3,250,383 1.47% 49,825,804 $
ONO PHARMACEUTICAL CO., LTD.
0.33%
 1,665,000 0.33% 27,002,820 $
ALFRESA HOLDINGS CORPORATION
0.81%
 1,641,120 0.81% 24,099,831 $
JCR PHARMACEUTICALS CO., LTD.
2.62%
 3,400,000 2.62% 19,297,618 $
TOHO HOLDINGS CO., LTD.
0.76%
 578,426 0.76% 13,957,593 $
MOCHIDA PHARMACEUTICAL CO., LTD.
1.45%
 541,600 1.45% 11,523,022 $
VITAL KSK HOLDINGS, INC.
2.31%
 1,199,000 2.31% 9,950,405 $
THE SHIGA BANK, LTD.
0.21%
 112,400 0.21% 3,115,518 $
HOKUYAKU TAKEYAMA HOLDINGS,INC.
1.92%
 468,000 1.92% 2,690,279 $
SUMITOMO PHARMA CO., LTD.
0.15%
 608,700 0.15% 1,600,729 $

Company contact information

Sumitomo Pharma Co., Ltd.

2-6-8 Dosho-machi Chuo-Ku

541-0045, Osaka

+81 6 6203 5321

http://www.sumitomo-pharma.co.jp
address Sumitomo Pharma Co., Ltd.(4506)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Sumitomo Pharma Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
410 JPY
Average target price
333.8 JPY
Spread / Average Target
-18.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SUMITOMO PHARMA CO., LTD. Stock Sumitomo Pharma Co., Ltd.
-12.02% 1.03B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.80% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.13% 231B
NOVARTIS AG Stock Novartis AG
+4.84% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.37% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4506 Stock
  4. Company Sumitomo Pharma Co., Ltd.